MedPage Today on MSN
After 5 Years, Acid-Reducer Is Back on the Market
The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled ...
A Dallas law firm is part of a team taking on some of the biggest drug-makers in a nationwide lawsuit that alleges that over-the-counter heartburn medication Zantac causes cancer. In April 2020, the ...
Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.
The U.S. Food and Drug Administration announced Wednesday a request for all manufacturers to withdraw all prescription and over-the-counter ranitidine drugs from the market immediately, including the ...
Oakland, California, June 24, 2022 (GLOBE NEWSWIRE) -- The California State Court Judge overseeing the Ranitidine Products Cases JCCP NO. 5150 issued a pretrial order this week establishing a trial ...
FDA clears reformulated ranitidine after five years, ensuring safety with new labeling and storage instructions for acid-reducing treatment.
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
TipRanks on MSN
FDA approves reformulated ranitidine tablets
The U.S. Food and Drug Administration approved reformulated ranitidine tablets, “marking the return of this important acid-reducing medication to ...
Millions of Americans suffer from acid reflux every year. If you’re one of them, you might have relied on the over-the-counter drug Zantac, known generically as Ranitidine, to alleviate your heartburn ...
Countless more patients buy it over the counter. If a bombshell petition filed with the FDA is correct, all those people might need to find another medication. The claim: Ranitidine may be prone to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results